We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600584:SSEJCET Group Co., Ltd. Class A Analysis

Data as of 2026-08-13 - not real-time

CN¥77.82

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At ¥77.82, JCET Group Co., Ltd. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 18.9%. RSI sits at 49.0, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at ¥60.84 up to resistance at ¥90.15.
On valuation the read is overvalued — earnings multiple of 84.6 versus a 36.6 sector average, above the peer group. Consensus targets land 10.9% above where the shares trade now. The 0.17% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 100.0%, a beta of 0.27 and a maximum drawdown of 42.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

Get the detailed quarterly/annual income statement for JCET Group Co.Today, JCET Group SSE: 600584 , a leading global provider of integrated circuit IC back-end manufacturing and...media 1032483 SHANGHAI, April 28, 2026 /PRNewswire/ -- JCET Group SSE: 600584 , a leading global provider of integrated...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading above the 200-day average of 54.98
  • MACD momentum is positive
  • 30-day price change of -18.9%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 84.6 versus sector average of 36.6
  • Trading above the 200-day average of 54.98
  • Analyst targets imply +10.9% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 84.6 versus sector average of 36.6
  • Analyst targets imply +10.9% versus the current price
  • Revenue contracting at -1.8%

Key Metrics & Analysis

Financial Health

Revenue Growth-1.80%
Profit Margin4.27%
P/E Ratio84.6
ROE5.39%
ROA2.36%
Debt/Equity38.55
P/B Ratio4.8
Op. Cash FlowCN¥5.3B
Free Cash FlowCN¥-4436569088
Industry P/E36.6

Technical Analysis

TrendNeutral
RSI49.0
SupportCN¥60.84
ResistanceCN¥90.15
MA 20CN¥75.95
MA 50CN¥84.02
MA 200CN¥54.98
MACDBullish
VolumeDecreasing
Fear & Greed Index95.3

Valuation

Fair ValueCN¥24.04
Target PriceCN¥86.33
Upside/Downside10.93%
GradeOvervalued
TypeGrowth
Dividend Yield0.17%

Risk Assessment

Beta0.27
Volatility100.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.